Skip to content
All news
Analysis

Morgan Stanley Raises Cerebras Systems Price Target to $273

Morgan Stanley raised its price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $273 from $250, keeping an Overweight rating, following the release of strong fiscal Q1 2026 results.

July 1, 2026
2 min read
Source: Insider Monkey
Share:

Key Numbers

new price target
$273
old price target
$250
rating
Overweight

Morgan Stanley raised its price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $273 from $250, maintaining an Overweight rating, on June 24, 2026. The revision comes after the company reported strong fiscal Q1 2026 results.

Rating Change

  • Before: Price target $250, Overweight rating.
  • After: Price target $273, Overweight rating.

Analyst Rationale

The Morgan Stanley analyst believes Cerebras Systems' Q1 2026 results exceeded expectations, boosting confidence in the company's growth prospects in the AI chip market. Strong demand for Cerebras' solutions, particularly for large language model training, was cited as a key driver.

Context

Cerebras Systems is a promising player in the AI chip space, drawing increased analyst attention since its IPO. Current coverage includes several investment banks with ratings ranging from Buy to Hold, and price targets between $200 and $300.

Conclusion

Morgan Stanley's price target hike reflects cautious optimism about Cerebras Systems' future. However, investors should consider the high volatility in the tech sector and intense competition from giants like NVIDIA.

Frequently Asked Questions

The new price target is $273 per share, up from $250.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.